166 related articles for article (PubMed ID: 26339045)
1. Epstein-Barr Viruses (EBVs) Deficient in EBV-Encoded RNAs Have Higher Levels of Latent Membrane Protein 2 RNA Expression in Lymphoblastoid Cell Lines and Efficiently Establish Persistent Infections in Humanized Mice.
Gregorovic G; Boulden EA; Bosshard R; Elgueta Karstegl C; Skalsky R; Cullen BR; Gujer C; Rämer P; Münz C; Farrell PJ
J Virol; 2015 Nov; 89(22):11711-4. PubMed ID: 26339045
[TBL] [Abstract][Full Text] [Related]
2. The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes.
Toczyski DP; Matera AG; Ward DC; Steitz JA
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3463-7. PubMed ID: 8159770
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation.
Wu Y; Maruo S; Yajima M; Kanda T; Takada K
J Virol; 2007 Oct; 81(20):11236-45. PubMed ID: 17686859
[TBL] [Abstract][Full Text] [Related]
4. Growth-promoting properties of Epstein-Barr virus EBER-1 RNA correlate with ribosomal protein L22 binding.
Houmani JL; Davis CI; Ruf IK
J Virol; 2009 Oct; 83(19):9844-53. PubMed ID: 19640998
[TBL] [Abstract][Full Text] [Related]
5. Cellular gene expression that correlates with EBER expression in Epstein-Barr Virus-infected lymphoblastoid cell lines.
Gregorovic G; Bosshard R; Karstegl CE; White RE; Pattle S; Chiang AK; Dittrich-Breiholz O; Kracht M; Russ R; Farrell PJ
J Virol; 2011 Apr; 85(7):3535-45. PubMed ID: 21248031
[TBL] [Abstract][Full Text] [Related]
6. Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2.
Pimienta G; Fok V; Haslip M; Nagy M; Takyar S; Steitz JA
PLoS One; 2015; 10(6):e0124638. PubMed ID: 26121143
[TBL] [Abstract][Full Text] [Related]
7. Consideration of Epstein-Barr Virus-Encoded Noncoding RNAs EBER1 and EBER2 as a Functional Backup of Viral Oncoprotein Latent Membrane Protein 1.
Herbert KM; Pimienta G
mBio; 2016 Jan; 7(1):e01926-15. PubMed ID: 26787829
[TBL] [Abstract][Full Text] [Related]
8. In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2).
Rochford R; Miller CL; Cannon MJ; Izumi KM; Kieff E; Longnecker R
Arch Virol; 1997; 142(4):707-20. PubMed ID: 9170499
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Epstein-Barr virus (EBV) type and variant in spontaneous lymphoblastoid cells and Hu-SCID mouse tumours.
Menin C; Ometto L; Veronesi A; Roncella S; Corneo B; Montagna M; Coppola V; Veronese ML; Indraccolo S; Amadori A; De Rossi A; Ferrarini M; Chieco-Bianchi L; D'Andrea E
Mol Cell Probes; 1996 Dec; 10(6):453-61. PubMed ID: 9025083
[TBL] [Abstract][Full Text] [Related]
10. The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.
Forte E; Salinas RE; Chang C; Zhou T; Linnstaedt SD; Gottwein E; Jacobs C; Jima D; Li QJ; Dave SS; Luftig MA
J Virol; 2012 Jun; 86(12):6889-98. PubMed ID: 22496226
[TBL] [Abstract][Full Text] [Related]
11. Exosomes released in vitro from Epstein-Barr virus (EBV)-infected cells contain EBV-encoded latent phase mRNAs.
Canitano A; Venturi G; Borghi M; Ammendolia MG; Fais S
Cancer Lett; 2013 Sep; 337(2):193-9. PubMed ID: 23684926
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection.
Yoshioka M; Ishiguro N; Ishiko H; Ma X; Kikuta H; Kobayashi K
J Gen Virol; 2001 Oct; 82(Pt 10):2385-2392. PubMed ID: 11562532
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer.
Wang J; Zheng X; Qin Z; Wei L; Lu Y; Peng Q; Gao Y; Zhang X; Zhang X; Li Z; Fu Y; Liu P; Liu C; Yan Q; Xiong W; Li G; Lu J; Ma J
J Biol Chem; 2019 Mar; 294(13):4854-4866. PubMed ID: 30674552
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G
J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640
[TBL] [Abstract][Full Text] [Related]
15. Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22.
Fok V; Mitton-Fry RM; Grech A; Steitz JA
RNA; 2006 May; 12(5):872-82. PubMed ID: 16556938
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus latent genes.
Kang MS; Kieff E
Exp Mol Med; 2015 Jan; 47(1):e131. PubMed ID: 25613728
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
18. Modulation of innate immunity system by Epstein-Barr virus-encoded non-coding RNA and oncogenesis.
Samanta M; Takada K
Cancer Sci; 2010 Jan; 101(1):29-35. PubMed ID: 19886912
[TBL] [Abstract][Full Text] [Related]
19. Ribosomal protein L22 inhibits regulation of cellular activities by the Epstein-Barr virus small RNA EBER-1.
Elia A; Vyas J; Laing KG; Clemens MJ
Eur J Biochem; 2004 May; 271(10):1895-905. PubMed ID: 15128299
[TBL] [Abstract][Full Text] [Related]
20. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL.
Kanemitsu N; Isobe Y; Masuda A; Momose S; Higashi M; Tamaru J; Sugimoto K; Komatsu N
Clin Cancer Res; 2012 Apr; 18(8):2164-72. PubMed ID: 22371452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
